Topical Corticosteroids Market to Worth $4,440.38 Million by 2024
The new published report titled “Global Topical Corticosteroids Market is expected to reach USD 4,440.38 million by 2024, from USD 2,828.36 million in 2016 growing at a CAGR of 5.8% in the forecast period 2017 to 2024”, also the Global Topical Corticosteroids Market By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Brands (Betnovate, Betnovate N, Panderm Plus, Lobate, Cosvate G, Clop G, Tenovate GN, Lobate GM, Ultiderm, Flutivate, Fexin, Momate, Candiderm, Others), Purchase Mode (OTC-Based, Prescription-Based), Application (Acne, Dermatitis, Psoriasis, Skin Infections, Hyperpigmentation, Melasma, Others), Medication Type (Ointments, Creams, Liquid & Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Potency Class, End User, Distribution Channel, Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
This report consists of below pages:
- No of pages: 350
- No of Figures: 60
- No of Tables: 220
Get Free Sample Copy of this Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-corticosteroids-market
The factors such as increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market. On the other hand, expiry of patent for drugs, weak reimbursement policies, and stringent regulatory policies may hinder the growth of the market. The topical corticosteroids market in the global region is leading in North America.
Segmentation of Global Topical Corticosteroids Market:
The global topical corticosteroids market is segmented on the basis of molecule name, brands, purchase mode, application, medication type, potency class, end user, distribution channel.
On the basis of molecule name, global topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others. In 2017, Fludroxycortide is expected to dominate the Global topical corticosteroids market with 26.2% market share and is expected to reach USD 229.42 million by 2024, growing at a CAGR of 7.2% in the forecast period 2017 to 2024.
On the basis of purchase mode, global topical corticosteroids market is segmented into segmented into OTC-based and prescription-based. In 2017, the prescription based market segment is expected to account for the largest share of 72.1% of the global topical corticosteroids market, by purchase mode.
The global topical corticosteroids market report, on the basis of brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.
On the basis of application, global topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, the psoriasis is one of the dominating sectors of global topical corticosteroids market with 40.5% market share, growing at the highest CAGR 6.5% in the forecast period 2017 to 2024.
The global topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments is expected to dominate the global topical corticosteroids market with 31.2% market share and is expected to reach USD 1,344.11 million by 2024, with a CAGR of 5.4% in the forecast period 2017 to 2024.
Order a copy of Topical Corticosteroids Market Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-corticosteroids-market
The Global topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, the moderate potency class market segment is expected to account for the largest share of 41.0% of the global topical corticosteroids market, by potency class. This segment is expected to grow at the highest CAGR of 6.4% in the forecast period 2017 to 2024.
The global topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, the dermatology clinics market segment is expected to account for the largest share of 43.5% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.6% in the forecast period 2017 to 2024.
The Global topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, the pharmacies stores market segment is expected to account for the largest share of 46.3% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.5% in the forecast period 2017 to 2024.
Key Drivers of Global Topical Corticosteroids Market:
Global topical corticosteroids market is growing with the increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market.
Key Points of Global Topical Corticosteroids Market:
- Global topical corticosteroids market is dominated by LEO Pharma, followed by Glaxosmithkline Plc and Pfizer Inc.
- Fludroxycortide segment is expected to dominate the global topical corticosteroids market.
- The topical corticosteroids market in the global region is leading in North America, Asia-Pacific, and Europe. North America accounts for the highest market share in this region.
Read more about the Global Topical Corticosteroids Market Report Visit @ http://databridgemarketresearch.com/reports/global-topical-corticosteroids-market/
TABLE OF CONTENTS:
- INTRODUCTION
- MARKET SEGMENTATION
- MARKET OVERVIEW
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME
6.1. OVERVIEW
6.2. FLUDROXYCORTIDE
6.3. TRIAMCINOLONE ACETONIDE
6.4. FLUOCINOLONE ACETONIDE
6.5. ANTISEPTICS
6.6. BETAMETHASONE
6.7. CLOBETASONE PROPIONATE
6.8. CLOBETASONE BUTYRATE
6.9. HALOBETASONE
6.10. MOMETASONE
6.11. OTHERS
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS
7.1. OVERVIEW
7.2. ULTRA HIGH
7.3. HIGH
7.4. MODERATE
7.5. MILD
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. ACNE
8.3. DERMATITIS
8.4. PSORIASIS
8.5. SKIN INFECTION
8.6. HYPERPIGMENTATION
8.7. MELASMA
8.8. OTHERS
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE
9.1. OVERVIEW
9.2. OINTMENTS
9.3. CREAMS
9.4. LIQUID & SOLUTIONS
9.5. LOTIONS
9.6. GEL
9.7. OILS
9.8. PASTES
9.9. SPRAYS
9.10. OTHERS
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER
10.1. OVERVIEW
10.2. HOSPITAL
10.3. DERMATOLOGY CLINICS
10.4. HOMECARE
10.5. OTHERS
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL
11.1. OVERVIEW
11.2. HOSPITAL PHARMACIES
11.3. PHARMACY STORES
11.4. ONLINE PHARMACIES
11.5. OTHERS
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE
12.1. OVERVIEW
12.2. OVER THE COUNTER (OTC) BASED
12.3. PRESCRIPTION BASED
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS
13.1. OVERVIEW
13.2. BETNOVATE
13.3. BETNOVATE N
13.4. PANDERM PLUS
13.5. LOBATE
13.6. COSVATE G
13.7. CLOP G
13.8. TENOVATE GN
13.9. LOBATE GM
13.10. ULTIDERM
13.11. FLUTIVATE
13.12. FEXIN
13.13. MOMATE
13.14. CANDIDERM
13.15. OTHERS
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.3. EUROPE
14.4. ASIA-PACIFIC
14.5. SOUTH AMERICA
14.6. MIDDLE EAST AND AFRICA
- GLOBAL TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: GLOBAL
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
- COMPANY PROFILES
16.1. GLAXOSMITHKLINE PLC.
16.2. MERCK & CO. INC.
16.3. LEO PHARMA
16.4. ALMIRALL S.A.
16.5. VALEANT PHARMACEUTICALS INTERNATIONAL
16.6. ZYLERA PHARMACEUTICALS
16.7. SANDOZ INTERNATIONAL GMBH
16.8. PFIZER INC.
16.9. SANOFI S.A.
16.10. ASTRAZENECA
Related Report
Global Biomarkers Market – Industry Trends and Forecast to 2024
Global Biomarkers Market, By Product Type (Consumables, Services, Softwares), Technology (Efficacy, Safety, Validation), Application (Diagnostics, Drug Discovery, Personalized Medicine, Disease Risk Assessment), Indication (Cancer, Cardiovascular, Immunological), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-biomarkers-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research